Streppel MT, Arends LR, van t Veer P, Grobbee DE, Geleijnse JM
The tinted version doubles as foundation
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
KWONG: Sydney Lupkin, thank you so much for joining us
GLP-1 stands for glucagon like peptide, a class of hormones, and theres also a related class called GIP or glucose dependent insulinotropic polypeptide
During the second half of the 19th century, the mental framework for whats now referred to as the incretin effect was first described [9]
